Endoscopic Changes of Tracheobronchial Tree Caused by Mucormycosis in Patients with a Novel Coronavirus Infection
https://doi.org/10.58838/2075-1230-2024-102-2-78-85
Abstract
The most severe manifestation of COVID-19 is bilateral pneumonia with development of acute respiratory distress syndrome accompanied by cytokine storm, pulmonary edema and death of the patient. In a number of patients, occurrence of mucormycosis of mucous membranes was one of the stages of the lethal outcome development. The arctile presents a clinical case of mucormycosis of the tracheobronchial tree detected by bronchoscopy several days before death in a patient with COVID-19 who was on mechanical ventilation. The endoscopic signs (endoscopic image) are described.
About the Authors
O. A. But
City Clinical Hospital no. 24, Moscow Health Department
Russian Federation
Russian Federation
Oksana A. But, Candidate of Medical Sciences, Head of Endoscopy Department
10 Pistsovaya St., Moscow, 127015
Phone: +7 (495) 613-87-01
L. V. Telegina
P. Hertsen Moscow Oncology Research Institute, the Branch of National Medical Research Radiological Centre, Russian Ministry of Health
Russian Federation
Russian Federation
Larisa V. Telegina, Doctor of Medical Sciences, Senior Researcher of Endoscopy Department
3 2nd Botkinsky Rd., Moscow, 125284
Phone: +7 (495) 150-11-22
S. S. Pirogov
P. Hertsen Moscow Oncology Research Institute, the Branch of National Medical Research Radiological Centre, Russian Ministry of Health
Russian Federation
Russian Federation
Sergey S. Pirogov, Doctor of Medical Sciences, Head of Endoscopy Department
3 2nd Botkinsky Rd., Moscow, 125284
Phone: +7 (495) 150-11-22
A. S. Vodoleev
P. Hertsen Moscow Oncology Research Institute, the Branch of National Medical Research Radiological Centre, Russian Ministry of Health
Russian Federation
Russian Federation
Aleksandr S. Vodoleev, Candidate of Medical Sciences, Head of Endoscopy Department
3 2nd Botkinsky Rd., Moscow, 125284
Phone: +7 (495) 150-11-22
D. G. Sukhin
P. Hertsen Moscow Oncology Research Institute, the Branch of National Medical Research Radiological Centre, Russian Ministry of Health
Russian Federation
Russian Federation
Dmitry G. Sukhin, Candidate of Medical Sciences, Senior Researcher of Endoscopy Department
3 2nd Botkinsky Rd., Moscow, 125284
Phone: +7 (495) 150-11-22
A. D. Kaprin
P. Hertsen Moscow Oncology Research Institute, the Branch of National Medical Research Radiological Centre, Russian Ministry of Health
Russian Federation
Russian Federation
Andrey D. Kaprin, Doctor of Medical Sciences, Academician of RAS, Professor, Director
3 2nd Botkinsky Rd., Moscow, 125284
Phone: +7 (495) 150-11-22
References
1. Veselova E.I., Russkikh A.E., Kaminsky G.D., Lovacheva O.V., Samoylova A.G., Vasilyeva I.A. Novel coronavirus infection. Tuberculosis and Lung Diseases, 2020, vol. 98, no. 4, pp. 6-14. (In Russ.) https://doi.org/10.21292/2075-1230-2020-98-4-6-14
2. Ismailova M.Kh., Yunusova L.R., Khaydarova G.B., Abdullaeva L.Sh. Multimodal imaging of maxillofacial complications in post-COVID-19 patients with diabetes mellitus. Vestnik Sovremennoy Klinicheskoy Meditsiny, 2023, vol. 16, suppl. 2, pp. 19-23. (In Russ.) https://doi.org/10.20969/VSKM.2023.16(suppl.2).19-23
3. Lipnitskiy A.V., Polovets N.V., Surkova R.S., Murugova A.A., Toporkov A.V., Viktorov D.V. COVID-19 and mucormycosis. Immunopatologiya, Allergologiya, Infektologiya, 2021, no. 4, pp. 65-71. (In Russ.) https://doi.org/10.14427/jipai.2021.4.65
4. Nerovny A.I., Panchenko I.G., Morenko M.V., Fedin A.V., Polyukhov E.V., Sycheva A.V. Mucormycosis in COVID-19 patients. Rossiyskaya Otorinolaringologiya, 2023, vol. 22, no. 3, pp. 8-14. (In Russ.) https://doi.org/10.18692/1810-4800-2023-3-8-14
5. Nurtdinova G.M., Suleymanov A.M., Bayazitov Yan.I., Khismatullina Z.R., Shamigulov F.B., Gumerov R.M., Agaydarova G.M., Zagidullin Sh.Z., Schekin S.V., Schekin V.S., Absalyamova D.F., Pavlov V.N., Zagidullin N.Sh. Clinical case of mucormycosis in patient COVID-19. Case report. Terapevticheskiy Arkhiv, 2022, vol. 94, no. 11, pp. 1320-1325. (In Russ.) https://doi.org/10.26442/00403660.2022.11.201942
6. Samsonova M.V., Chernyaev A.L., Lebedin Yu.S., Mikhaylichenko K.Yu., Polivanova A.E. Pulmonary mucormycosis. Pulmonologiya, 2018, vol. 28, no. 2, pp. 243-247. (In Russ.) https://doi.org/10.18093/0869-0189-2018-28-2-243-247
7. Taraskina A.E., Pchelin I.M., Ignatieva S.M., Spiridonova V.A., Uchevatkina A.E., Filippova L.V., Frolova E.V., Vasilieva N.V. Molecular genetic methods for detection and species identification of fungal order mucorales in accordance with global guideline for diagnosis and management of mucormycosis (literature review). Problemy Meditsinskoy Mikologii, 2020, vol. 22, no. 1, pp. 3-14. (In Russ.) https://doi.org/10.24412/1999-6780-2020-1-3-14
8. Al-Tawfiq J.A., Alhumaid S., Alshukairi A.N., Temsah M.H., Barry M., Al Mutair A., Rabaan A.A., Al-Omari A., Tirupathi R., AlQahtani M., AlBahrani S., Dhama K. COVID-19 and mucormycosis superinfection: the perfect storm. Infection, 2021, vol. 49, no. 5, pp. 833-853. https://doi.org/10.1007/s15010-021-01670-1
9. Jackson C.B., Farzan M., Chen B., Choe H. Mechanisms of SARS-CoV-2 entry into cells. Nat. Rev. Mol. Cell. Biol., 2022, vol. 23, no. 1, pp. 3-20. https://doi.org/10.1038/s41580-021-00418-x
10. Kharat A., Simon M., Guérin C. Prone position in COVID 19 - associated acute respiratory failure. Curr. Opin. Crit. Care, 2022, vol. 1, no. 28, pp. 57-65. https://doi.org/10.1097/MCC.0000000000000900
11. Pal R., Singh B., Bhadada S.K., Banerjee M., Bhogal R.S., Hage N., Kumar A. COVID-19-associated mucormycosis: An updated systematic review of literature. Mycoses, 2021, vol. 64, no. 12, pp. 1452-1459. https://doi.org/10.1111/myc.13338
12. Ragab D., Salah Eldin H., Taeimah M., Khattab R., Salem R. The COVID-19 cytokine storm; what we know So Far. Front Immunol., 2020, no. 11, pp. 1446. https://doi.org/10.3389/fimmu.2020.01446.eCollection2020
13. Richardson S., Hirsch J.S., Narasimhan M., Crawford J.M., McGinn T., Davidson K.W. et al. Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with COVID-19 in the New York City Area. JAМA, 2020, vol. 323, no. 2, pp. 2052-2059. https://doi:10.1001/jama.2020.6775
14. Stockdale A.J., Fyles F., Farrell C. et al. Sensitivity of SARS-CoV-2 RNA polymerase chain reaction using a clinical and radiological reference standard. J. Infect., 2021, vol. 82, no. 6, pp. 260-268. https://doi.org/10.1016/j.jinf.2021.04.012
15. Swenson K.E., Swenson E.R. Pathophysiology of Acute Respiratory Distress Syndrome and COVID-19 Lung Injury. Crit. Care Clin., 2021, vol. 37, no. 4, pp. 749-776. https://doi.org/10.1016/j.ccc.2021.05.003
16. WHO Coronavirus Disease (COVID-19) Dashboard. Available: https://covid19.who.int/ Accessed March 21, 2021
17. Wiersinga W.J., Rhodes A., Cheng A.C., Peacock S.J., Prescott H.C. Pathophysiology, transmission, diagnosis, and treatment of coronavirus disease 2019 (COVID-19): a review. JAMA, 2020, vol. 324, no. 8, pp. 782-793. https://doi.org/10.1001/jama.2020. 12839.PMID: 32648899
Review
For citations:
But O.A., Telegina L.V., Pirogov S.S., Vodoleev A.S., Sukhin D.G., Kaprin A.D. Endoscopic Changes of Tracheobronchial Tree Caused by Mucormycosis in Patients with a Novel Coronavirus Infection. Tuberculosis and Lung Diseases. 2024;102(2):78-85. (In Russ.) https://doi.org/10.58838/2075-1230-2024-102-2-78-85
Views:
301
Email this article 